XML 67 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Income Tax Benefit Recognized for our Share-Based Compensation Arrangements
Compensation cost included in income from continuing operations, primarily selling, general and administrative expense, and the income tax benefit recognized for our share-based compensation arrangements is included below:
 
 Years Ended December 31,
 202220212020
 (In thousands)
Total share-based compensation cost$23,454 $22,627 $17,405 
Income tax benefit5,582 5,385 4,142 
Schedule of Fair Values for SARs and Stock Options Estimated on Grant Date Using Black-Scholes-Merton Option-Pricing Formula Which Incorporates Assumptions
 Years Ended December 31,
 202220212020
 (In thousands, except weighted average fair
value and assumptions)
Weighted-average fair value of SARs granted$21.85 $18.30 $18.29 
Total intrinsic value of SARs exercised4,384 1,581 545 
Tax benefit from SARs exercised678 327 26 
Weighted-average fair value of restricted stock units granted61.61 51.76 41.75 
Total fair value of restricted stock units vested16,830 12,623 6,600 
Expected volatility43.00 %45.34 %37.55 %
Expected term (in years)5.65.75.7
Risk-free rate1.89 %0.70 %1.44 %
Dividend yield0.37 %0.44 %0.39 %
Summary of Share Based Compensation Activity
 SARsRestricted Stock Units
 NumberWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual Term		Aggregate
Intrinsic Value		NumberWeighted-
Average
Grant-Date
Fair Value
  (In thousands, except exercise prices, fair values, and contractual terms)
Outstanding at January 1, 20221,244 $63.18 n/an/a964 $50.08 
Granted165 53.83 n/an/a395 61.61 
Exercised or converted(340)56.18 n/an/a(307)54.70 
Forfeited or expired(111)62.64 n/an/a(155)51.37 
Outstanding at December 31, 2022958 $64.13 4.8$10,017 897 $54.59 
Vested or expected to vest at December 31, 2022282 $50.19 8.5$6,132 
Exercisable or convertible at December 31, 2022676 $69.95 3.3$3,885